Breaking News
We Bought 8.7 Acres for $14,000 - Now We Are Greening the Desert with Earth Smiles
Dear America, We Do Not Beat China in the AI Race if We Become China in the AI Race
Bot Farms, JD Vance, NATO, Charlie Kirk, Israel & the Globalist Propaganda Network Connecting It All
The Number of Regular People Being Arrested for Protesting Data Centers Is Astounding
Top Tech News
Idaho's High Desert Becomes Hot Spot For Nuclear Power Revolution
The World's Largest Electric Aircraft Is About to Take Its First Flight
Tesla Cybercabs and Superchargers Will Act as Mini Cell Towers for SpaceX Starlink
Elon Vows AI-Made 'Odyssey' After Blasting Nolan's Take On Homer
Anthropic is launching its own drug discovery programs for rare diseases using Claude...
SpaceX AI Satellites Will Have 250 Kilowatts of Power
Chinese researchers have developed a sodium-metal battery that can fully charge in just 4 minutes...
SpaceX Starship Flight 13 in 3 Days - Thursday July 13
Chinese Scientists Develop Nuclear Battery Using Carbon-14
Teleoperated humanoid robots complete first-ever live surgery
Anti-Aging Researcher David Sinclair Takes Metformin, NMN, NAD for Longevity
In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.